Company Profile
iRadimed Stock Price, News & Analysis
- Ticker:
- IRMD
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
91.21 USD (-0.71%)
Close
Last updated: August 6, 2026
1.15B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, IRMD closed down 0.71% at $91.21. No new same-company headline was identified in the current news window.
Company overview
MRI-Compatible Device Specialist
IRADIMED is a medical device company focused on products designed for use during magnetic resonance imaging procedures. Its core portfolio includes non-magnetic IV infusion pump systems and patient vital signs monitoring systems, along with related accessories, disposables, and services. This gives the company a narrow but defensible position in a clinical environment where standard equipment can create safety and workflow challenges.
Infusion Pump Platform Transition
The company's near-term operating story is centered on the launch of the 3870 MR IV pump, a next-generation platform that is replacing revenue from the older 3860 pump. Initial shipments began during the second quarter of 2026, with management describing the period as the first sizable production ramp for the new pump. Customer demand appears to be shifting toward higher-channel configurations, with more than 70% of new pump orders placed for the four-pump "quad stack" setup.
Monitoring Systems and Domestic Base
IRADIMED also sells MRI-compatible patient monitoring systems, and domestic monitor unit bookings reached a record level during the quarter. Domestic sales remain the majority of revenue, giving the business strong exposure to U.S. hospital MRI-suite capital and workflow spending.
Strategic Position
IRADIMED is best understood as a focused MRI safety and workflow company rather than a broad hospital equipment supplier. Its differentiation comes from designing devices specifically for the MRI environment, where non-magnetic design, regulatory clearance, and clinical reliability matter. Near-term performance depends on the 3870 pump ramp, monitor demand, manufacturing efficiency, and continued hospital adoption of MRI-compatible systems.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of iRadimed (IRMD)?
iRadimed (IRMD) most recently closed at 91.21 USD, a -0.71% move versus the previous session.
What is the market cap of iRadimed (IRMD)?
iRadimed currently has a market capitalization of 1.15B USD on BioPharmSignal.
What does iRadimed do?
MRI-Compatible Device Specialist IRADIMED is a medical device company focused on products designed for use during magnetic resonance imaging procedures. Its core portfolio includes non-magnetic IV infusion pump systems and patient vital signs monitoring systems, along with related accessories, disposables, and services. This gives the company a narrow but...
On which exchange is IRMD stock listed?
iRadimed (IRMD) is associated with NASDAQ, United States, Biopharma.
What is MRI-Compatible?
MRI-Compatible Device Specialist IRADIMED is a medical device company focused on products designed for use during magnetic resonance imaging procedures.
Which conditions is iRadimed targeting with MRI-Compatible?
MRI-Compatible Device Specialist IRADIMED is a medical device company focused on products designed for use during magnetic resonance imaging procedures. Its core portfolio includes non-magnetic IV infusion pump systems and patient vital signs monitoring systems, along with related accessories, disposables, and services. This gives the company a narrow but...
What is Device?
MRI-Compatible Device Specialist IRADIMED is a medical device company focused on products designed for use during magnetic resonance imaging procedures.
What is Specialist?
MRI-Compatible Device Specialist IRADIMED is a medical device company focused on products designed for use during magnetic resonance imaging procedures.